Results 231 to 240 of about 633,561 (259)
Some of the next articles are maybe not open access.

Treatment-Free Remission in Patients With Chronic Myeloid Leukaemia

Nature Reviews Clinical Oncology, 2020
David Ross, Timothy Hughes
exaly  

Inqovi for Acute Myeloid Leukemia

The Medical Letter on Drugs and Therapeutics
The FDA has approved Inqovi (Taiho Oncology), a fixed-dose combination of the nucleoside metabolic inhibitor decitabine and the cytidine deaminase inhibitor cedazuridine, for use in combination with venetoclax (Venclexta, and generics) for oral treatment of newly diagnosed acute myeloid leukemia (AML) in adults who are ≥75 years old or who have ...
openaire   +2 more sources

Epigenetics in Acute Myeloid Leukemia

Medical Epigenetics, 2016
Carmela Dell'Aversana, Lucia Altucci
exaly  

Acute Myeloid Leukaemia

Nature Reviews Disease Primers, 2016
Rosemary Gale   +2 more
exaly   +2 more sources

The Difficult Problem of Acute Myeloid Leukemia in the Older Adult

Ca-A Cancer Journal for Clinicians, 2002
Richard M Stone
exaly  

Single-Cell Mutation Analysis of Clonal Evolution in Myeloid Malignancies

Nature, 2020
Ahmet Zehir, Kelly Bolton, Aaron Viny
exaly  

Minimal Residual Disease in Acute Myeloid Leukaemia

Nature Reviews Clinical Oncology, 2013
Christopher S Hourigan, Judith E Karp
exaly  

Tyrosine Kinase Inhibitors in Chronic Myeloid Leukaemia: Which, When, for Whom?

Nature Reviews Clinical Oncology, 2017
Gianantonio Rosti   +2 more
exaly  

Home - About - Disclaimer - Privacy